Chemotherapy-induced Peripheral Neuropathy (CIPN) Clinical Trials

14 recruitingLast updated: June 17, 2026

There are 14 actively recruiting chemotherapy-induced peripheral neuropathy (cipn) clinical trials across 9 countries. Studies span Not Applicable, Phase 3, Phase 2. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Las Palmas, Las Palmas, Spain. Updated daily from ClinicalTrials.gov.


Chemotherapy-induced Peripheral Neuropathy (CIPN) Trials at a Glance

14 actively recruiting trials for chemotherapy-induced peripheral neuropathy (cipn) are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Boston, New York, and Las Palmas. Lead sponsors running chemotherapy-induced peripheral neuropathy (cipn) studies include Bernardino Clavo, MD, PhD, Luminate Medical, Inc., and Dana-Farber Cancer Institute.

Browse chemotherapy-induced peripheral neuropathy (cipn) trials by phase

Treatments under study

About Chemotherapy-induced Peripheral Neuropathy (CIPN) Clinical Trials

Looking for clinical trials for Chemotherapy-induced Peripheral Neuropathy (CIPN)? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chemotherapy-induced Peripheral Neuropathy (CIPN) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chemotherapy-induced Peripheral Neuropathy (CIPN) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

Chemotherapy-induced Peripheral Neuropathy (CIPN)
Luminate Medical, Inc.142 enrolled18 locationsNCT07142304
Recruiting
Phase 3

Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)
University Health Network, Toronto240 enrolled1 locationNCT07481149
Recruiting
Phase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

painful peripheral neuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Diabetic Peripheral Neuropathic Pain (DPN)+1 more
University of Rochester190 enrolled7 locationsNCT06614322
Recruiting
Not Applicable

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

Breast Cancer PatientsChemotherapy-induced Peripheral Neuropathy (CIPN)Paclitaxel-induced Peripheral Neuropathy
Tuba Eryiğit30 enrolled1 locationNCT06964802
Recruiting

Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)Healthy
University of Florida30 enrolled1 locationNCT07009717
Recruiting
Not Applicable

Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients

Breast CancerChemotherapy-induced Peripheral Neuropathy (CIPN)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University384 enrolled1 locationNCT07377279
Recruiting
Not Applicable

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Chemotherapy-induced Peripheral Neuropathy (CIPN)NeuropathyPeripheral Neuropathy Due to Chemotherapy+1 more
Dana-Farber Cancer Institute21 enrolled1 locationNCT06807294
Recruiting

Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial

Chemotherapy-induced Peripheral Neuropathy (CIPN)Neuropathic Pain
University of Palermo40 enrolled1 locationNCT07352514
Recruiting

Evaluation of Effectiveness of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy for Treatment of Chemotherapy Induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy (CIPN)Neuropathic Pain
Rijnstate Hospital20 enrolled5 locationsNCT07304401
Recruiting
Phase 3

GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer

Chemotherapy-induced Peripheral Neuropathy (CIPN)
Qilu Pharmaceutical Co., Ltd.352 enrolled1 locationNCT06994507
Recruiting
Not Applicable

The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy (CIPN)
Universiteit Antwerpen206 enrolled2 locationsNCT06962579
Recruiting
Not Applicable

Effect of Adding Electroacupuncture to Anti-cancer Therapy-induced Peripheral Neuropathy

CancerChemotherapy-induced Peripheral Neuropathy (CIPN)
Zhongnan Hospital150 enrolled1 locationNCT06858709
Recruiting
Phase 2Phase 3

Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).

Chemotherapy-induced Peripheral Neuropathy (CIPN)NumbnessParesthesia+1 more
Bernardino Clavo, MD, PhD42 enrolled1 locationNCT06799351
Recruiting
Phase 2Phase 3

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy (CIPN)NumbnessParesthesia+1 more
Bernardino Clavo, MD, PhD42 enrolled1 locationNCT06706544